Repurposing - finding new uses for old (and patented) drugs: bridging the "Valley of Death," to translate academic research into new medicines.
›
Linked as:Extract
Repurposing - finding new uses for old (and patented) drugs: bridging the "Valley of Death," to translate academic research into new medicines.
No longer available (Autolink)
See the full content of this document
This document cites
- Federal Cases - 572 F.Supp. 255 (E.D.N.Y. 1983), CV 83-4312, Roche Products, Inc. v. Bolar Pharmaceuticals Co., Inc.
- Federal Cases - 381 F.Supp.2d 452 (D.Md. 2005), Civ. WDQ-04-2607, Classen Immunotherapies, Inc. v. Biogen IDEC
- Federal Cases - 733 F.2d 858 (Fed. Cir. 1984), 84-560, Roche Products, Inc. v. Bolar Pharmaceutical Co., Inc.
- Federal Cases - 659 F.3d 1057 (Fed. Cir. 2011), 2006-1634, Classen Immunotherapies, Inc. v. Biogen IDEC
- Federal Cases - 686 F.3d 1348 (Fed. Cir. 2012), 2012-1062, Momenta Pharmaceuticals, Inc. v. Amphastar Pharmaceuticals, Inc.
